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Abstract
Background: For reliable assessment of ventilation inhomogeneity, multiple-breath washout (MBW) systems should be
realistically validated. We describe a new lung model for in vitro validation under physiological conditions and the
assessment of a new nitrogen (N2)MBW system.
Methods: The N2MBW setup indirectly measures the N2 fraction (FN2) from main-stream carbon dioxide (CO2) and side-
stream oxygen (O2) signals: FN2 = 12FO22FCO22FArgon. For in vitro N2MBW, a double chamber plastic lung model was filled
with water, heated to 37uC, and ventilated at various lung volumes, respiratory rates, and FCO2. In vivo N2MBW was
undertaken in triplets on two occasions in 30 healthy adults. Primary N2MBW outcome was functional residual capacity
(FRC). We assessed in vitro error (![difference]2) between measured and model FRC (100–4174 mL), and error between tests
of in vivo FRC, lung clearance index (LCI), and normalized phase III slope indices (Sacin and Scond).
Results: The model generated 145 FRCs under BTPS conditions and various breathing patterns. Mean (SD) error was 2.3
(1.7)%. In 500 to 4174 mL FRCs, 121 (98%) of FRCs were within 5%. In 100 to 400 mL FRCs, the error was better than 7%. In
vivo FRC error between tests was 10.1 (8.2)%. LCI was the most reproducible ventilation inhomogeneity index.
Conclusion: The lung model generates lung volumes under the conditions encountered during clinical MBW testing and
enables realistic validation of MBW systems. The new N2MBW system reliably measures lung volumes and delivers
reproducible LCI values.
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Introduction
Multiple-breath inert gas washout (MBW) tests are used to
assess uniformity of ventilation distribution in infants, children,
and adults [1]. Both global indices of ventilation inhomogeneity
such as the lung clearance index (LCI) and specific indices of non-
uniform gas mixing in the conducting and acinar airway zones (Scond
and Sacin) are frequently reported [2–6]. The accuracy of these
indices relies directly or indirectly on correctly measured
functional residual capacity (FRC). Therefore current guidelines
for lung function testing recommend in vitro FRC measurements
over the full range of lung volumes in question at various
respiratory frequencies [7,8].
FRC measurement validation is commonly assessed using
calibration syringes to simulate FRC and tidal breathing washout
[9]. However, in vivo accuracy of FRC measurements depends on
the individual performance under physiological conditions of the
gas and flow sensors used, ignored by the syringe. Given the
increasing interest in MBW as a clinical outcome measure there is
an urgent need for improved validation models which incorporate
conditions encountered during clinical testing (i.e. variations in
temperature, pressure and humidity over the breath cycle).
This report describes (i) the development and utility of a lung
model incorporating simulated body temperature, pressure and
water vapor saturation (BTPS) conditions, and (ii) the in vitro and in
vivo performance of a commercial N2MBW system (Exhalyzer DH,
Eco Medics AG, Duernten, Switzerland). Primary outcome was
the accuracy and precision with which FRC can be generated and
measured in vitro and the reproducibility of FRC in vivo in healthy
adults. Secondary outcomes were the reproducibility of ventilation
inhomogeneity indices and their correlation in healthy adults.
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Methods
Nitrogen multiple-breath washout setup
We used an unmodified open-circuit N2MBW hardware and
software package (Exhalyzer DH and SpirowareH 3.1, Eco Medics
AG) for all recordings, and an in-house customized software based
on TestPointTM (Capital Equipment Corp, Billerica, MA, USA)
for off-line data processing and analyses. Flow was measured using
a mainstream ultrasonic flowmeter and used to derive tidal
volumes [10]. Gas concentrations were measured by a side-stream
laser O2 sensor (Oxigraf, Inc, Mountain View, CA, USA) and a
main-stream infra-red CO2 sensor (CapnostatH 5, Respironics
Novametrix LLC, Wallingford, CT, USA). In this device, FN2 is
measured indirectly based on Dalton’s law of partial pressures:
FN2 = 12FO22FCO22FArgon (FArgon = FN2 * 0.00934/0.78084).
The FArgon (0.00934) is treated as a fixed proportion of the FN2
assuming similar washout during N2MBW. Daily two-point
calibration and verification of the flow and O2 sensors, and zero
calibration of the CO2 sensor were performed. The O2 sensor has
a slower 10–90% response time (140 ms) than the CO2 sensor
(55 ms). To align their signals, a speeding algorithm was applied to
the O2 signal reducing its response to approximately 110 ms
[11,12]. Gas signals were synchronized to the flow signal using the
re-inspired post-capillary dead space to produce a step response in
CO2 and O2. The gas signal vectors were time shifted to the point
in time when the post-capillary dead space had been inhaled such
that a 50% change in gas signal deflection then occurred. This was
repeated over a minimum of ten washout breaths and median
‘‘delay times’’ for CO2 (50 ms) and O2 (565 ms) were used for
signal alignment. Quality of superimposition of the inverted O2
signal on the CO2 signal was assessed visually.
Lung (model) resident FN2 was washed out using 100% O2
applied via open circuit at either 200 mL/s for 100–400 mL FRCs
or at 1000 mL/s for 500–4200 mL FRCs and in vivo, respectively
(Figure 1). These bypass flows were chosen to exceed maximum
tidal inspiratory flows and to minimize rebreathing of CO2 or N2.
For respective lung volumes (Table 1) we used post-capillary dead
space reducers (infant set 1, preschool set 2, adult set 3) and
hygienic inserts (Spirette) provided by the manufacturer (Eco
Medics AG). These reduced equipment related post-capillary dead
space (volume between CO2/O2 sampling point and bypass) to
1.5 mL, 16 mL, and 26.9 mL, respectively, as measured by water
displacement. Bacteria filters (air eco slimline, Vickers Ind Est, LA,
UK) had 30 mL dead space and were used for preschool and adult
sets. Accordingly, pre-capillary dead space (volume between lung
compartment top and CO2/O2 sampling point) was 37.9 mL in
the large model and 3 mL in the small model, respectively.
Apparatus resistance was measured by a pressure transducer
(Timeter RT200, Allied Healthcare Products Inc., MO, USA). We
applied pure O2 and increased flows stepwise between 0–200 mL/
s for the infant set, 0–500 mL/s for the preschool set, and 0–
770 mL/s for the adult set with bacteria filters in place. Maximum
resistances were 0.03, 0.06, and 0.19 kPa/L*s, respectively, and
complied with the recommendations of previous standards [8,13].
The lung model
The framework of the lung model was constructed from acrylic
glass (Soloplex, Tidaholm, Sweden) and consisted of two rigid
chambers: An inner chamber divided into two communicating
compartments (via their lower aspect) termed the lung and the
ventilation compartment, and an outer chamber (Figure 1). Two
different size models were constructed to allow for both infant (100
to 400 mL) and children/adult (500 to 4200 mL) lung model
volumes. The inner chamber was filled with distilled water until
the desired FRC was achieved, measured as the end-expiratory
water level using a transparent vertical tape measure fixed to the
lung compartment. FRC volume was determined geometrically
from known dimensions: one millimeter corresponded to 18.7 mL
in the large and to 4.8 mL in the small lung model. The lung
model was placed inside a water tank which served to heat the
water in the inner chamber to 37uC, monitored using a
thermostat. To simulate various breathing patterns, a bi-level
positive airway pressure ventilator (Vivo 30, Breas Medical AB,
Mo¨lnlycke, Sweden) for the large lung model, or a 100 mL
calibration syringe (Hans Rudolph Inc, Shawnee, KS, USA) for
the small lung model was connected to the top of the ventilation
compartment and exerted hydraulic pressure transmitted through
to the lung compartment. During ventilation, temperature and
humidity were measured every third FRC trial inside the lung
Figure 1. Schematic drawing of the lung model. The lung and
ventilation compartments are partly filled with distilled water, their
volumes are 6.94 L and 11.72 L, respectively. The outer chamber’s
volume is 67.73 L, filled with distilled water and constantly heated to
37uC. The dashed line reflects the water level determining tidal volume
and functional residual capacity (FRC) at in- and expiratory end-tidal
levels. FRC is the volume of air contained in the model at end-tidal
expiration. One mm on the tape measure corresponds to 18.7 mL
volume. FRC range is 0.5–4.2 L. O2 = sampling point of the side-stream
oxygen sensor. CO2 = sampling point of the main-stream carbon dioxide
sensor. Flowhead=main-stream ultrasonic flowmeter.
doi:10.1371/journal.pone.0036083.g001
Table 1. Study protocol for the lung model.
Lung model DSR Trial (n) FRC (mL) VT (mL) RR (min
21)
Small 1 7 100–400 30–80 20–35
Large 2 10 500–2000 150–540 12–29
Large 3 33 2000–4200 190–880 10–29
Functional residual capacity (FRC), tidal volume (VT), and respiratory rate (RR)
generated in triplets are displayed as ranges. Respective dead space reducers
(DSR 1–3) were applied to reduce post-capillary dead space to 1.5 mL, 16 mL,
and 26.9 mL, respectively. Mean (range) intra-test coefficient of variation (CV) of
generated nominal FRCs was 0.1 (0.0–1.8)%.
doi:10.1371/journal.pone.0036083.t001
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compartment using a thermocouple thermometer (BAT-12
Microprobe Thermometer, Physitemp Instruments, Inc. New
Jersey, USA) and a monolithic humidity sensor (HIH-4602-L-CP,
linear humidity sensor, Honeywell, Minneapolis, USA).
In vitro study
Static signal linearity of the N2MBW system was assessed over
the full range of O2, CO2, and N2 fractions encountered during
N2MBW testing and performed at 37uC with 100% relative
humidity: By increasing FO2 stepwise (60 steps), FO2 ranged from
15–100%, FCO2 from 0–6%, and FN2 from 0–79%. The reference
for measured gas concentrations was a respiratory mass spec-
trometer (AMIS 2000; Innovision A/S, Odense, Denmark).
In vitro assessments of the N2MBW system performance were
undertaken as triplicate FRC measurements (n = 150) across 50
different nominal FRCs (100 to 4200 mL), over two days.
Ventilator pressures in the large model or syringe stroke volumes
in the small volume were chosen to achieve physiological tidal
volumes (VT), VT over FRC ratios (VT/FRC), and respiratory
rates (RR) for each FRC setting (Table 1). To assess the possible
influence of different FCO2 on FRC measurement accuracy, the
lung compartment was washed-in with either ambient air (0.05%
CO2) or CO2 enriched air (n = 45, CarboairH, Aiolos Medical,
Karlstad, Sweden) prior to N2MBW. CarboairH contains 5% CO2
and balance air.
In vivo study
Thirty-two healthy adults performed N2MBW on two test
occasions within a three week period. All subjects had a
standardized interview on respiratory health. Inclusion criteria
were adults aged 19 to 70 years with a smoking history less than
five pack-years, no history of acute or chronic airway disease, and
no on-going medication potentially affecting lung function.
N2MBW was performed in the sitting position using a nose clip
with the dead space reducer (set 3), hygienic insert, and bacterial
filter in place. N2MBW was done in triplets with between-test
intervals exceeding the washout time. The subjects were instructed
to breathe regularly with relaxed expirations. The washout phase
was terminated once end-tidal FN2 was less than 1/40
th of the
starting FN2 for at least three breaths.
Ethics statement
The in vivo study was approved by the Ethics Committee of the
University of Gothenburg Sweden. We obtained informed consent
from all participants involved in the study.
Nitrogen multiple-breath washout outcomes
FRC was calculated as net expired N2 volume (expired N2
volume minus re-inspired N2 volume) divided by the difference of
FN2 at start of MBW minus FN2 at end of MBW. Pre-capillary
dead space was subtracted from FRC such that the reported FRC
corresponds to the volume of the inner compartment of the lung
model or FRC at the airway opening in the in vivo recordings.
Indices of ventilation inhomogeneity were calculated from in vivo
N2MBW trials. Because LCI, Sacin, and Scond relate inversely to
ventilation efficiency, their values increase with increasing
ventilation inhomogeneity. LCI was calculated as cumulative
expired gas volume (CEV) required to reduce FN2 to 1/40
th of the
starting FN2, divided by FRC. Two phase III slope (SIII) indices,
Scond and Sacin, were calculated. Automated SIII fitting over 50–
95% of expired volume was performed for each breath and
manually adjusted to exclude phase II or IV from the linear
regression fit. SIII was normalized (SnIII) by dividing SIII by the
mean FN2 over SIII and multiplying SIII with VT, and averaged per
breath from the three N2MBWs [14]. Mean SnIII per breath was
then plotted against the corresponding mean lung volume
turnover (TO=CEV/FRC) for each breath. Scond is defined as
the rate of SnIII increase between lung volume turnovers 1.5 and
6.0. Sacin is defined as the first breath SnIII value minus the
convection-dependent inhomogeneity contribution to this value
[15].
Statistics
Linearity of sensors compared to mass spectrometry was
assessed using uni-variable linear regression and respective signal
offsets (linear model intercept) and gains (linear model slope) with
their 95% confidence intervals (CI) were reported. Intra-test
variability of both model and measured FRCs as generated by the
model and measured by the N2MBW setup, respectively, was
calculated as intra-test coefficient of variation (CV=SD/
mean*100). Accuracy of FRC measurements was expressed as (i)
absolute (mL) difference (difference between measured FRC minus
model FRC), (ii) relative (%) difference (difference*100 divided by
model FRC), and as (iii) relative error (square-root of the squared
relative difference). Acceptable upper limit was 5% error
according to current infant lung function standards [7]. We
reported coefficient of repeatability (CR) calculated as 1.96*SD of
differences between paired measurements [16]. The CR estimates
the 95% range of technical variability due to measurement error in
vitro or the technical and physiological between-test variability in
vivo. We assessed Bland Altman plots [16], and the relation of error
with FRC, breathing pattern, different lung model gases, and
between tests using uni- and multi-variable linear regression
models and paired t-tests. P-values,0.05 were considered
statistically significant and all analyses were done using StataTM
(Stata Statistical Software: Release 11. College Station, TX:
StataCorp LP).
Results
Lung model performance
The lung model successfully generated 146 (97%) out of 150
FRCs (range 100–4174 mL) under BTPS conditions. Mean (SD)
of temperature and humidity were 35.9 (1.3)uC and 97.9 (1.0)%,
respectively, obtained from 18 measurements. Following water
refilling, four gas temperature drops of 3uC were observed and
respective FRC recordings were subsequently excluded. Realistic
breathing patterns were applied with VT between 30 and 877 mL,
VT/FRC between 0.14 and 0.55, and RR between 10 and
35 min21. The intra-test variability of FRCs generated by the lung
models was low overall, CV mean (SD) was 0.07 (0.31)%, and
lower in the large model compared to the small model: CV mean
(SD) was 0.03 (0.15)% and 0.23 (0.64)%, p= 0.108, respectively.
The potential parallax error of reading water levels using the tape
measure was estimated as one mm corresponding to 18.7 mL and
4.8 mL in the large and small lung model, respectively. Relating
these volumes to the nominal FRC, the relative mean (range)
parallax error was 1.2 (0.4–3.7)% and 2.9 (1.2–4.8)% in the large
lung and small model, respectively.
In vitro performance of the nitrogen multiple-breath
washout setup
The O2, CO2, and N2 signals were linear over the full range. R
2
was .0.99 for all signals (Table 2). The N2MBW setup accurately
measured FRC with low intra-test variability (Figure 2, Table 3).
Of 146 FRC measurements one measurement was excluded due
to incomplete N2 washout. In 48 triplicate FRC measurements,
Validation of a Multiple-Breath Washout System
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mean (SD) of CV was 1.4 (1.7)%. Absolute mean (SD) difference
between measured and model FRC was 9.2 (52.3) mL, relative
difference was 20.2 (2.9)%. Of 145 FRCs measured between
100 mL and 4200 mL, 130 (90%) FRC measurements were
within the 5% of model FRCs (Figures 2, 3). Mean (SD) error was
2.3 (1.7)% in all measurements. In the large lung model (500 to
4174 mL FRCs), 121/124 (98%) of FRCs were within the 5%
error limit, error range was 0.0–6.5%. In the small lung model
(100 to 400 mL FRCs), 9 (43%) out of 21 FRCs were within the
5% error limit, error range was 1.0–7.1%.
Errors in FRC measurements in lung models containing either
ambient or CO2 enriched air were similar. Comparing the mean
(SD) error using ambient air (n = 102) vs. CO2 enriched air
(n = 43), the mean (SD) error was 2.2 (1.7)% vs. 2.6 (1.8)%,
p= 0.185. Errors in FRCs measurements recorded on day one
(n = 72) vs. day two (n= 73) differed, mean (SD) error 1.6 (1.0)% vs.
2.1 (1.4)%, p= 0.024. There was a positive association between
error and RR (R2= 0.24, p,0.001), and negative associations with
VT (R
2= 0.16, p,0.001), mean expiratory flow (R2= 0.15,
p,0.001), measurement duration (R2 = 0.12, p,0.001), and
FRC (R2= 0.09, p,0.001). Accounting for RR in a multi-variable
regression model, the association of error with mean expiratory
flow remained significant (p = 0.036) but not with VT, measure-
ment duration, or FRC.
In vivo performance of the nitrogen multiple-breath
washout setup
Thirty out of 32 healthy adults (15 females) successfully
performed N2MBW on two test occasions with a mean (SD) of
12.2 (5.1) days in between. Mean (range) age was 49.3 (21–69)
years. Two males did not achieve leak-free N2MBW. All subjects
had normal spirometry indices. Mean (SD) z-scores [17] of forced
expiratory volume in one second (FEV1), FEV1/forced vital
capacity, and forced expiratory flow between 25–75% of expired
volume (FEF25–75) were 0.75 (0.86), 0.24 (0.81), and 0.32 (0.82),
respectively.
In vivo FRC intra-test variability was greater than measured in
model FRC: CV mean (SD) was 4.5 (3.2)% vs. 1.4 (1.7)%,
p,0.001. Likewise the in vivo FRC error between tests was greater
compared to the in vitro FRC error measured in the models: Error
mean (SD) was 10.1 (8.2)% vs. 2.3 (1.7)%, p,0.001. Reproduc-
ibility of ventilation inhomogeneity indices differed significantly
with the LCI representing the most reproducible index (Table 3).
In vivo reproducibility for LCI was better than for FRC, and
markedly better than for Sacin and Scond (Figures 4, 5). LCI was
correlated with Sacin (Pearson r = 0.61, p,0.001) but not with Scond
(r = 0.17, p = 0.377). Sacin was correlated with Scond (r = 0.44,
Figure 2. In vitro variability of functional residual capacity measurement. Bland Altman plot [16] of measured functional residual capacity
(FRC) minus lung model FRC plotted vs. mean of measured and model FRC. Differences (open circles), and mean difference, and upper and lower
limits of agreement (mean difference 61.96 SD of differences) are given as dashed lines for the small lung model and as solid lines for the large lung
model. Figure 2a gives absolute FRC differences (mL). For the small and large lung model, mean differences are 210.2 mL and 12.5 mL, upper limits
of agreement are 9.9 mL and 121.9 mL, and lower limits of agreement are 230.3 mL and 296.8 mL, respectively. Figure 2b gives relative FRC
differences (%). For the small and large lung model, mean differences are 23.8% and 0.4%, upper limits of agreement are 3.6% and 4.7%, and lower
limits of agreements are 211.2% and 24.0%, respectively.
doi:10.1371/journal.pone.0036083.g002
Figure 3. Association of measurement error with lung volume.
Functional residual capacity (FRC) measurement error (%) is plotted
against lung model FRC. The error data are displayed as open circles for
the small model (100–400 mL FRCs) and closed circles for the large
model (500–4200 mL FRCs). The dashed line gives the 5% limit of
acceptable measurement error, the dotted lines reflect possible
nominal volume bias due to reading parallax error (one mm) in the
small and large lung model.
doi:10.1371/journal.pone.0036083.g003
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p= 0.016). Estimates of repeatability (CV) and reproducibility
(CR) of FRC and ventilation inhomogeneity indices were not
associated with number of days between tests or the subject’s age
and gender (data not shown).
Discussion
Summary
This is the first study demonstrating that an available N2MBW
system accurately and reliably measures FRC over the wide range
of lung volumes and different breathing patterns encountered from
early childhood to adulthood. This study also shows that BTPS
conditions can be implemented into lung model studies to bench-
test MBW equipment under realistic conditions. In vitro FRC can
be measured with only 5% error over FRC volumes between 600
and 4200 mL with the N2MBW system. In FRCs below 600 mL,
the error is better than 7%. N2MBW measurements in healthy
adults show that LCI is more reproducible than FRC, Sacin, and
Scond. Variability of FRC measured in vivo is higher than in vitro
suggesting substantial physiological fluctuation of FRC in humans
[18].
Comparison to previous lung model studies
Data on quality of signals and their integration under realistic
conditions are essential for appropriate evaluation of MBW setups
[19]. As an initial step, linearity of O2, CO2, and N2 signals was
confirmed over the full measurement range in heated humid
conditions encountered during clinical N2MBW testing. We
improved a lung model described by Brunner et al. [20], which
was originally ventilated manually and the water contained within
the model was not heated. In addition to the incorporation of
BTPS conditions, physiological breathing patterns were applied.
These conditions recreate the stress the system is exposed to during
clinical testing across wide age ranges. Previous in vitro lung models
lacked one or more important physiological aspects [21–25].
The current N2MBW system precisely measures lung volumes
between 600 and 4200 mL. In this volume range approximating
late preschool age to large sized adults, the in vitro measurement
error was below 5% in all FRCs (Figure 3). Importantly, this
N2MBW system is not susceptible to different FCO2. Indirect N2
measurement may be susceptible to drift in FCO2 as the current N2
signal or, e.g. molar mass, are sum signals of gas fractions including
the FCO2 [26].
This study is able to disentangle technical from physiological
aspects contributing to FRC variability. Comparing the in vitro CR
of FRC (4.6%) with in vivo (24.9%), inherent physiological
variability of FRC may explain 20.3% (or relatively 82%) of
between-test variability in adults. Validation studies exclusively
performed in vivo do not allow differentiation between technical
and physiological variability [24,27]. In infants, the FRC error
between tests may exceed 20% [28,29].
Ventilation inhomogeneity indices
The current N2MBW setup can be easily applied to measure
ventilation inhomogeneity indices in vivo. These measures correlate
as shown previously [15,30]. LCI, in particular, had high
repeatability and reproducibility in healthy adults. The specific
indices of non-uniform gas mixing in the conducting and acinar
airway zones (Scond and Sacin) were more variable. Between-test
reproducibility of LCI (CR=9.5%) was markedly higher than for
Sacin (49.2%) and Scond (41.4%). In a recent study [31],
comparable between-test reproducibility of LCI, Sacin, and Scond
was reported in healthy adults performing a sulfur hexafluoride
MBW protocol with tidal breathing restricted to one liter VT. The
small technical error of FRC observed in vitro strongly suggests
higher physiological variability of these SnIII indices compared to
volume indices (FRC, LCI). SnIII depends on breathing pattern
Table 2. Linearity of sensors.
Offset Gain
Mean 95% CI Mean 95% CI R2
Oxygen (%) 20.47 20.79 to 20.15 1.01 1.00 to 1.01 .0.99
Carbon
dioxide (%)
20.05 20.12 to 0.02 1.08 1.06 to 1.10 .0.99
Nitrogen (%) 0.09 20.17 to 0.35 0.99 0.98 to 1.00 .0.99
Oxygen and carbon dioxide and the derived nitrogen signals from the nitrogen
multiple-breath washout setup were compared to mass spectrometer signals
(AMIS 2000). Linear regression derived intercept (model offset), model slope
(model gain) with respective 95% confidence intervals (CI), and R-squared (R2)
are given.
doi:10.1371/journal.pone.0036083.t002
Table 3. Nitrogen multiple-breath washout outcomes and variability.
In vitro nitrogen multiple-breath washout outcomes
Mean (SD) CV (%) Mean diff. (95% CI)1 CR CR (%)
FRC* (mL) 207.5 (107.0) 2.7 (2.0) 210.2 (25.5; 214.9) 20.1 mL 9.7%
FRC{ (mL) 2360.0 (1186.1) 1.0 (1.4) 12.5 (2.6; 22.5) 109.3 mL 4.6%
In vivo nitrogen multiple-breath washout outcomes
FRC{ (mL) 3249.6 (728.3) 4.5 (3.2) 215.4 (2169.5; 138.7) 808.7 mL 24.9%
LCI 7.19 (0.53) 3.2 (1.7) 20.13 (20.26; 0.00) 0.68 9.5%
Sacin 0.063 (0.029) n.a. 0.001 (20.005; 0.007) 0.031 49.2%
Scond 0.019 (0.005) n.a. 0.000 (20.002; 0.001) 0.008 41.4%
Triplicate nitrogen multiple-breath washout (N2MBW) tests applied to measure functional residual capacity (FRC) in vitro in the small
* (n = 7) and the large{ lung model
(n = 41), and in 30 healthy adults{. LCI = lung clearance index. Sacin = phase III slope index of acinar ventilation inhomogeneity. Scond = phase III slope index of conductive
ventilation inhomogeneity. CV = intra-test coefficient of variation (SD/mean*100). Mean difference1 (95% confidence interval) from paired t-tests comparing measured
and actual model FRC [in vitro] or N2MBW outcomes between two test occasions [in vivo]. CR = coefficient of repeatability (1.96*SD of differences between measured
and actual model FRC or differences of N2MBW outcomes between tests). CR is given in respective units or as percentage of the mean. n.a. = not applicable.
doi:10.1371/journal.pone.0036083.t003
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[32], which was not restricted in this study. Interestingly, LCI is
even more reproducible than FRC as also shown in healthy
children [33]. This may reflect the fact that LCI is a robust volume
ratio (CEV/FRC), cancelling the effect of physiological changes in
lung volumes.
Limitations
While the large lung model was suited for the MBW bench test,
the small model may require adjustments. Automated ventilation
and a laser sensor for determining nominal FRC could improve
the infant lung model. Parallax error in the large model was small
enough to avoid over- or underestimation of nominal FRCs
(Figure 3).
Within the small technical measurement error of FRC, RR and
tidal flow were correlated with error. Whether this association was
causal leading to signal asynchrony or rather a surrogate for flow-
dependent temperature and humidity fluctuations hampering
adequate BTPS correction remains to be determined [10]. We
hypothesize that the apparatus dead space volumes behave as
systems taking up and delivering heat energy and moisture non-
linearly over breath cycles. Reduced dead space and dynamic
BTPS and synchronization algorithms may further decrease
measurement error.
The current and previous models did not allow assessment of
‘‘tissue’’ N2 contribution to the lung inherent FN2. This
contribution is difficult to estimate and account for, as available
data are limited [34]. In adults with more advanced lung disease,
duration of N2MBW and bias from tissue N2 may increase, and
intervals between tests should be adapted accordingly [8].
Implications
Availability of realistic validation protocols will aid the transition
of MBW from promising research tool into routine clinical use.
This is the first validation of an available N2MBW setup using
Figure 4. In vivo variability of functional residual capacity. Bland Altman plot [16] of functional residual capacity (FRC) measured on two study
days within three weeks in 30 healthy adults. Absolute FRC differences (Figure 4a), relative FRC differences (Figure 4b), mean difference and upper
and lower limits of agreement (lines) are plotted against mean FRC of both tests. Mean difference is 215.4 mL (21.1%), upper and lower limits of
agreement are 793.3 mL (23.2%) and 2824.1 mL (225.4%).
doi:10.1371/journal.pone.0036083.g004
Figure 5. In vivo variability of lung clearance index. Bland Altman plot [16] of lung clearance index (LCI) measured on two study days within
three weeks in 30 healthy adults. Absolute LCI differences (Figure 5a), relative LCI differences (Figure 5b), mean difference and upper and lower limits
of agreement (lines) are plotted against mean LCI of both study days. Mean difference is20.13 (21.8%), upper and lower limits of agreement are 0.55
(7.6%) and 20.81 (211.2%).
doi:10.1371/journal.pone.0036083.g005
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physiological in vitro test conditions. Many other MBW setups
remain to be validated and are either customized, expensive, or
have been taken off the market [2,3,9,35]. N2MBW is also
advantageous to using foreign tracer gases because 100% O2 is
economic, readily available in all hospitals, and non-polluting.
The between-test variability of ventilation inhomogeneity
indices reported here sheds further light on their natural variability
over time. The CR aids estimating clinically relevant change in
lung function outcomes for future intervention studies. Given a
hypothetical intervention in the current study, a decrease of LCI of
0.68 units (9.5%) would constitute a physiological change with
95% probability. Further longitudinal studies in disease groups,
such as cystic fibrosis where variability is increased, are required
[36–38]. In infants and preschool-aged children, safety of N2MBW
and variability of N2MBW indices need to be determined.
Conclusion
The performance of MBW setups can be realistically assessed
using a new in vitro lung model producing BTPS conditions and
representative breathing patterns. This lung model protocol is
suitable for validation of other MBW systems. The new N2MBW
system accurately and precisely measures lung volumes between
600 and 4200 mL. Future work may extend this into smaller lung
volumes and younger age groups. The LCI represents the most
reproducible N2MBW in vivo outcome as compared to FRC, Scond,
and Sacin. This study may aid the transition of this important type
of lung function test from being a promising research tool to
becoming a routine method in clinical practice.
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